Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026029
Filing Date
2021-05-10
Accepted
2021-05-10 16:02:43
Documents
46
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q gern-10q_20210331.htm   iXBRL 10-Q 2369986
2 EX-31.1 gern-ex311_6.htm EX-31.1 17403
3 EX-31.2 gern-ex312_7.htm EX-31.2 17417
4 EX-32.1 gern-ex321_9.htm EX-32.1 8267
5 EX-32.2 gern-ex322_8.htm EX-32.2 8249
  Complete submission text file 0001564590-21-026029.txt   7683859

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gern-20210331.xsd EX-101.SCH 28647
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gern-20210331_cal.xml EX-101.CAL 45333
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gern-20210331_def.xml EX-101.DEF 97954
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gern-20210331_lab.xml EX-101.LAB 283947
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gern-20210331_pre.xml EX-101.PRE 194633
11 EXTRACTED XBRL INSTANCE DOCUMENT gern-10q_20210331_htm.xml XML 1717172
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Filer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20859 | Film No.: 21907005
SIC: 2834 Pharmaceutical Preparations